Insider Transactions in Q3 2022 at Alignment Healthcare, Inc. (ALHC)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2022
|
Warburg Pincus Partners Gp LLC Director |
SELL
Open market or private sale
|
Indirect |
2,044,006
-10.24%
|
$28,616,084
$14.61 P/Share
|
|
Sep 20
2022
|
Warburg Pincus LLC Director |
SELL
Open market or private sale
|
Indirect |
2,044,006
-10.24%
|
$28,616,084
$14.61 P/Share
|
|
Sep 20
2022
|
General Atlantic (Aln Hlth), L.P. Director |
SELL
Open market or private sale
|
Indirect |
6,955,994
-10.24%
|
$97,383,916
$14.61 P/Share
|
|
Sep 20
2022
|
General Atlantic LLC Director |
SELL
Open market or private sale
|
Indirect |
6,955,994
-10.24%
|
$97,383,916
$14.61 P/Share
|
|
Sep 12
2022
|
Richard A. Cross SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
102,759
+20.41%
|
-
|
|
Sep 12
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
280,360
+18.85%
|
-
|
|
Sep 12
2022
|
Dawn Christine Maroney President, Markets |
BUY
Grant, award, or other acquisition
|
Direct |
431,323
+17.88%
|
-
|
|
Sep 12
2022
|
Robert Thomas Freeman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
319,179
+30.38%
|
-
|
|
Sep 12
2022
|
John E Kao Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,639,027
+40.38%
|
-
|
|
Sep 09
2022
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
450
-0.03%
|
-
|
|
Sep 09
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
10,250
-0.66%
|
$164,000
$16.6 P/Share
|
|
Sep 08
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-5.12%
|
$800,000
$16.05 P/Share
|
|
Sep 01
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
20,000
-1.27%
|
$280,000
$14.56 P/Share
|
|
Sep 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-2.98%
|
$420,000
$14.56 P/Share
|
|
Sep 01
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-1.75%
|
$700,000
$14.56 P/Share
|
|
Sep 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-3.89%
|
$336,000
$14.56 P/Share
|
|
Aug 23
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-4.73%
|
$800,000
$16.0 P/Share
|
|
Aug 23
2022
|
Warburg Pincus Partners Gp LLC Director |
SELL
Open market or private sale
|
Indirect |
682,000
-3.3%
|
$10,230,000
$15.5 P/Share
|
|
Aug 23
2022
|
Warburg Pincus LLC Director |
SELL
Open market or private sale
|
Indirect |
682,000
-3.3%
|
$10,230,000
$15.5 P/Share
|
|
Aug 23
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
13,713
-0.86%
|
$205,695
$15.93 P/Share
|
|
Aug 22
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
16,287
-1.01%
|
$244,305
$15.9 P/Share
|
|
Aug 15
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
1,790
-0.11%
|
$28,640
$16.6 P/Share
|
|
Aug 11
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
500,000
-14.93%
|
$7,500,000
$15.95 P/Share
|
|
Aug 09
2022
|
Warburg Pincus Partners Gp LLC Director |
SELL
Open market or private sale
|
Indirect |
2,120,000
-9.31%
|
$33,920,000
$16.16 P/Share
|
|
Aug 09
2022
|
Warburg Pincus LLC Director |
SELL
Open market or private sale
|
Indirect |
2,120,000
-9.31%
|
$33,920,000
$16.16 P/Share
|
|
Aug 08
2022
|
General Atlantic (Aln Hlth), L.P. Director |
SELL
Open market or private sale
|
Indirect |
2,120,000
-3.03%
|
$33,920,000
$16.9 P/Share
|
|
Aug 08
2022
|
General Atlantic LLC Director |
SELL
Open market or private sale
|
Indirect |
2,120,000
-3.03%
|
$33,920,000
$16.9 P/Share
|
|
Aug 05
2022
|
Jeffrey H Margolis Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.28%
|
$21,600
$18.0 P/Share
|
|
Aug 05
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
44,104
-2.01%
|
$793,872
$18.76 P/Share
|
|
Aug 05
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
43,410
-3.3%
|
$781,380
$18.76 P/Share
|
|
Aug 05
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
66,191
-0.97%
|
$1,191,438
$18.78 P/Share
|
|
Aug 02
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
848
-0.02%
|
$11,872
$14.74 P/Share
|
|
Aug 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-2.65%
|
$420,000
$14.49 P/Share
|
|
Aug 01
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
20,000
-1.23%
|
$280,000
$14.47 P/Share
|
|
Aug 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
24,000
-3.51%
|
$336,000
$14.5 P/Share
|
|
Aug 01
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
49,152
-1.42%
|
$688,128
$14.6 P/Share
|
|
Jul 11
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
4,107
-0.12%
|
$57,498
$14.08 P/Share
|
|
Jul 08
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
14,775
-0.9%
|
$206,850
$14.3 P/Share
|
|
Jul 08
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
20,699
-0.59%
|
$289,786
$14.33 P/Share
|
|
Jul 07
2022
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
25,225
-1.51%
|
$353,150
$14.12 P/Share
|
|
Jul 07
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
49,442
-0.7%
|
$692,188
$14.09 P/Share
|
|
Jul 06
2022
|
John E Kao Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,752
-0.72%
|
$334,776
$13.04 P/Share
|
|
Jul 06
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.74%
|
$260,000
$13.04 P/Share
|
|
Jul 05
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
16,317
-1.4%
|
$195,804
$12.41 P/Share
|
|
Jul 05
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
20,383
-2.89%
|
$244,596
$12.48 P/Share
|
|
Jul 01
2022
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
12,000
-1.68%
|
$132,000
$11.4 P/Share
|
|
Jul 01
2022
|
Dinesh M. Kumar Chief Med & Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.85%
|
$110,000
$11.4 P/Share
|